NeuroCreate raises £150k from Jenson Funding Partners to develop its AI creativity platform
The seed round was backed by Jenson Funding Partners to support product development and team growth.
NeuroCreate develops a software platform that combines artificial intelligence and neuroscience to enhance workplace creativity and cognitive performance. Its flagship tool assists professionals during ideation and strategy tasks.
NeuroCreate has secured £150k in a seed funding round backed by Jenson Funding Partners. The capital will be directed towards expanding the team and building out collaborative web functionality for the company's AI-driven creativity platform.
The business develops software that uses neuroscience to help professionals navigate innovation and creative tasks. Trials have shown improvements in creative productivity and mental flexibility, positioning the firm within the future of work and enterprise wellbeing sectors.
Chief Investment Officer Jeffrey Faustin noted the firm's interdisciplinary approach and research credentials as key drivers for the investment. The injection follows prior backing from Innovate UK and recognition across several industry showcases.
From the founder
"Creativity is a critical commercial skill for organisations to foster in order to outperform in terms of growth, revenue and market share, and importantly employee wellbeing as well as productivity. There is therefore a huge amount of value to be derived by enhancing creative mental states through our innovative approach of ‘Neurodesign’ – designing ethical digital products for enhancing the human mind to thrive. It is our belief that a key component of the Future of Work will be the use of AI and neuroscience to augment the creative process and help employees achieve the “Flow” state. Not only will this improve productivity and outputs for organisations but it will also have a profound impact on employee engagement. We are delighted to have received the backing of Jenson as part of our Seed round, and are looking forward to attracting more investment to expand our vision in the Future of Work of helping professionals to develop their peak performance, augment their creative-thinking and mindset, and enhance their cognitive health towards a sustainable productive workflow."
Shama Rahman
CEO at NeuroCreate
Investor perspective
"NeuroCreate is an exciting proposition that sits at the cross-section between science, technology and the creative industries. There are many interdisciplinary uses of AI that are yet to be realised and NeuroCreate is exploring one that has a great deal of potential because of the focus that has been placed on employee wellness and productivity over the past few years. The team behind NeuroCreate also has all of the right credentials, knowledge and research to truly lead in this area and unlock the power of creativity for companies."
Jeffrey Faustin
Partner and CIO, Jenson Funding Partners
Use of funds
- 01Continue product development
- 02Grow the team
Investors
About the company
NeuroCreate
AI and neuroscience platform designed to augment professional creativity and cognitive health.